Open Beta
MetriLume

US marketsCSBR

SEC-sourced researchBeta

CSBR

CHAMPIONS ONCOLOGY, INC.

Company comparison ↗

Data passport

CIK
0000771856
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Sep 11, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: April 2025: 56,944,000.0000 USD; April 2026: 59,425,000.0000 USD59.4M USD0 USD0April 2025April 2026
CSBR · Exact amounts and source periods · USD
Period endRevenueFiling date
April 202556,944,000.0000Jul 27, 2026
April 202659,425,000.0000Jul 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
April 202659,425,000.0000-1,175,000.0000-4,472,000.000026,989,000.000022,921,000.0000Jul 27, 2026
April 202556,944,000.00004,701,000.00007,386,000.000032,344,000.000028,572,000.0000Jul 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$59.43MApril 2026Jul 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$56.94MApril 2025Jul 27, 202610-K
Net incomeProfitLoss-$1.18MApril 2026Jul 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$4.47MApril 2026Jul 27, 202610-K
Total assetsAssets$26.99MApril 2026Jul 27, 202610-K
Total liabilitiesLiabilities$22.92MApril 2026Jul 27, 202610-K

New filings

Explore methodology ↗